BioCentury
ARTICLE | Company News

Watson Pharmaceuticals news

June 28, 1993 7:00 AM UTC

Watson Pharmaceuticals (WATS) Watson Pharmaceuticals (WATS) said it has reacquired worldwide rights for Buprenorphine, a synthetic opiate analgesic, and Prochlorperazine, an anti-emetic, from an undi...